21 insiders reported 141 Form 4 transactions for BIOGEN INC. (BIIB) over the past 18 months (most recent 2026-06-11). Recent activity: SHERWIN STEPHEN A (Director) Buy 1,505 shares, HAWKINS WILLIAM A (Director) Buy 1,505 shares, Rowinsky Eric K (Director) Buy 1,505 shares, Freire Maria C (Director) Buy 2,005 shares, Mantas Jesus B (Director) Buy 1,505 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | SHERWIN STEPHEN A | Director | Buy | 1,505 | $0 |
| 2026-06-11 | HAWKINS WILLIAM A | Director | Buy | 1,505 | $0 |
| 2026-06-11 | Rowinsky Eric K | Director | Buy | 1,505 | $0 |
| 2026-06-11 | Freire Maria C | Director | Buy | 2,005 | $0 |
| 2026-06-11 | Mantas Jesus B | Director | Buy | 1,505 | $0 |
| 2026-06-11 | Patolawala Monish D | Director | Buy | 1,505 | $0 |
| 2026-06-11 | LANGER SUSAN | Director | Buy | 1,505 | $0 |
| 2026-06-11 | Pangalos Menelas N | Director | Buy | 2,370 | $0 |
| 2026-06-11 | Minor Lloyd | Director | Buy | 1,505 | $0 |
| 2026-06-11 | Pangalos Menelas N | Director | Buy | 1,505 | $0 |
| 2026-04-03 | Godbout Sean | Chief Accounting Officer | Buy | 181 | $0 |
| 2026-04-03 | Godbout Sean | Chief Accounting Officer | Sell | 54 | $9,924 |
| 2026-02-17 | Murphy Nicole | Head of Pharm Ops and Tech | Buy | 3 | $585 |
| 2026-02-10 | Singhal Priya | Head of Development | Buy | 2,217 | $0 |
| 2026-02-10 | Singhal Priya | Head of Development | Sell | 1,056 | $212,446 |
| 2026-02-10 | Singhal Priya | Head of Development | Buy | 4,683 | $0 |
| 2026-02-10 | Singhal Priya | Head of Development | Sell | 1,412 | $284,066 |
| 2026-02-10 | Singhal Priya | Head of Development | Sell | 2,660 | $531,548 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Buy | 257 | $0 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Sell | 76 | $15,290 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Buy | 305 | $0 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Sell | 103 | $20,722 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Buy | 517 | $0 |
| 2026-02-10 | Godbout Sean | Chief Accounting Officer | Sell | 180 | $36,212 |
| 2026-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | Buy | 2,102 | $0 |
Source: SEC Form 4 filings · as of 2026-06-11